PFE Stock Recent News

Paul Argenti, Dartmouth Tuck School of Business professor, joins 'Squawk Box' to discuss news of activist investor Starboard Value amassing a roughly $1 billion stake in drugmaker Pfizer, whether Pfizer makes sense as an activist target, and more.

The futures market is showing a downward trend this morning. The S&P 500 futures are down 24 points, the Nasdaq 100 futures have fallen 110 points, and the Dow Jones Industrial Average futures have decreased by 161 points.

Pfizer Inc. PFE may have been a hero in the COVID-19 vaccine race, but its stock is stuck in the slow lane. Down nearly 14% over the last year, the pharma giant's shares have struggled as demand for its pandemic-related treatments has fizzled out.

Activist investor Starboard Value is seeking to spur a turnaround of Pfizer, taking a stake of about $1 billion in the struggling pharmaceuticals giant, according to a person familiar with the matter. Charlie Wells reports on Bloomberg Television.

Activist investor Starboard Value has reportedly amassed a $1 billion stake in Pfizer.

In a bid to reshape Pfizer's future, activist investor Starboard Value has acquired a stake worth approximately $1 billion, according to reports. The move comes as the pharmaceutical giant faces mounting challenges, including declining demand for its Covid-19 products and increased competition.

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer Inc (NYSE:PFE, ETR:PFE) and is pushing for changes at the pharmaceutical giant, according to the Wall Street Journal. While Starboard's specific plans remain unclear, it has reportedly engaged with former Pfizer executives Ian Read and Frank D'Amelio to support its efforts.

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday.

Pfizer has prepared for today's challenges

A 5.8% forward-dividend yield is just one reason the hedge fund manager likes this stock.